Analyst Insights - Digital Health Posts

Read our Analysts’ insights and expert opinions on the latest healthcare technology industry developments and market trends. Signify Research provides both free insights and premium insights which are only available to subscribers of "Signify Premium Insights".
Click on the premium insights link below to filter for just the premium content.

Nihon Kohden’s Acquisition of AMP3D Further Highlights Interest of Analytics in the Clinical World

19th August 2021 – On the 27th of July 2021, the US subsidiary of Nihon Kohden (Nihon Kohden Digital Health Solutions, Inc.) announced that it was to acquire 100% of the shares of US-based Advanced Medical Predictive Devices, Diagnostics and Displays, Inc. (“AMP3D”)

Signify Premium Insights: Zebra Acquisition Gives Nanox Chance to Earn its Stripes

Signify Premium Insights Subscription Required

17th August 2021 – Last week, upstart modality vendor Nanox announced it was acquiring AI developer Zebra Medical Vision and radiology service provider USARAD. An unexpected move, but, as this Premium Insight asks, is it a stroke of genius or an ill-considered plan?

Signify Premium Insight: A Study in Validation

Signify Premium Insights Subscription Required

13th August 2021 – The medical imaging AI market has been hindered by the lack of clinical validation studies. This is starting to change with several recent studies bolstering the market, while also offering a glimpse of what’s to come.

Total VC Funding for AI in Drug Development & Clinical Trials Hits $10.7Bn

12th August 2021 – The market for AI in drug development and clinical trials has seen renewed interest in recent months, with total funding in the industry now reaching $10.7Bn. Click to download our free investment analysis.

Signify Premium Insight: GE Readies for the Future at HIMSS 2021

Signify Premium Insights Subscription Required

11th August 2021 – GE has revealed its new TruePACS radiology diagnostic reading and workflow solution at HIMSS 2021. The new solution represents a big step for GE, but what does it mean for the market?